SMITH ASSET MANAGEMENT GROUP LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 82 filers reported holding ANI PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$134,000
-15.7%
2,1800.0%0.01%0.0%
Q3 2019$159,000
-65.8%
2,180
-61.5%
0.01%
-62.5%
Q2 2019$465,000
+16.5%
5,6600.0%0.02%
+23.1%
Q1 2019$399,000
-48.4%
5,660
-67.1%
0.01%
-51.9%
Q4 2018$774,000
-42.9%
17,190
-28.3%
0.03%
-30.8%
Q3 2018$1,355,000
+2.3%
23,960
+20.9%
0.04%
+2.6%
Q2 2018$1,324,000
+32.9%
19,820
+15.8%
0.04%
+15.2%
Q1 2018$996,000
-74.8%
17,110
-71.3%
0.03%
-71.6%
Q3 2016$3,960,000
+18.8%
59,690
-0.1%
0.12%
+16.0%
Q2 2016$3,334,000
+9425.7%
59,720
+5754.9%
0.10%
+9900.0%
Q2 2014$35,000
+9.4%
1,0200.0%0.00%0.0%
Q1 2014$32,0001,0200.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders